Skip to main content
Stacey A. Honda, MD, PhD
Medical Director
Contact Info
Phone : (808) 432-8801
Email : Stacey.Honda@kp.org

Dr. Honda is associate medical director, Research, Laboratory/Pathology & Diagnostic Imaging, chief of Pathology, medical director of Laboratories, CIHR medical director, and director of Point of Care Testing. She is also an investigator on several federally funded studies and is site PI of the National Kaiser Permanente Research Bank.

Dr. Honda’s broad research interests span many areas of medicine with specific interest in cancer research, genetic/molecular research, pharmacogenomics, as well as comparative effectiveness and care delivery research. In her role as CIHR medical director, she serves as a liaison between research and care delivery.

Selected Publications:

  • Loudig O, Wang T, Ye K, Lin J, Wang Y, Ramnauth A, Liu C, Stark A, Chitale D, Greenlee R, Multerer D, Honda S, Daida Y, Spencer Feigelson H, Glass A, Couch FJ, Rohan T, Ben-Dov IZ. Evaluation and Adaptation of a Laboratory-Based cDNA Library Preparation Protocol for Retrospective Sequencing of Archived MicroRNAs from up to 35-Year-Old Clinical FFPE Specimens. Int J Mol Sci. 2017 Mar 14;18(3). doi: 10.3390/ijms18030627. PubMed PMID: 28335433; PubMed Central PMCID: PMC5372640.
  • Adjemian J, Frankland TB, Daida YG, Honda S, Olivier KN, Zelazny A, et al. Epidemiology of nontuberculous mycobacterial lung disease and tuberculosis, Hawaii, USA. Emerg Infect Dis. 2017 Mar
  • Chubak J, Ziebell R, Greenlee RT, Honda S, Hornbrook MC, Epstein M, Nekhlyudov L, Pawloski PA, Ritzwoller DP, Ghai NR, Feigelson HS, Clancy HA, Doria-Rose VP, Kushi LH. The Cancer Research Network: a platform for epidemiologic and health services research on cancer prevention, care, and outcomes in large, stable populations. Cancer Causes Control. 2016 Nov;27(11):1315-1323.
  • Larson EB, Tachibana C, Thompson E, Coronado GD, DeBar L, Dember LM, Honda S, Huang SS, Jarvik JG, Nelson C, Septimus E, Simon G, Johnson KE. Trials without tribulations: Minimizing the burden of pragmatic research on health care systems. Healthc (Amst). 2016 Sep;4(3):138-41. doi: 10.1016/j.hjdsi.2015.07.005.

Full List of Publications:

Studies: 

COMPARING TWO GESTATIONAL DIABETES SCREENING METHODS: A PRAGMATIC OUTPATIENT RCT

This project randomizes two different screening strategies for diabetes in pregnancy, among a study population of over 17,500 pregnant women and their babies (over 35,000 total) in a large diverse HMO, to determine how diagnosis and treatment based on these two strategies in routine clinical care affects complications for the baby and the mother.

R01HD074794

Sponsor: NIH/NICHD

Subcontract to Kaiser Permanente Northwest

KPHI Co-Investigator: Stacey Honda, MD, PhD

MOLECULAR MARKERS OF RISK OF SUBSEQUENT INVASIVE BREAST CANCER IN WOMEN WTH DUCTAL CARCINOMA IN SITU

Ductal carcinoma in situ (DCIS) of the breast is a non-invasive non-obligate precursor of invasive breast cancer (IBC), but currently it is not clear which DCIS patients will develop subsequent IBC. Using molecular approaches for analysis of DCIS specimens, our goal is to identify/validate molecular markers associated with risk of IBC development. The findings of this study might enhance the development of molecular markers for prediction of IBC risk and also improve the clinical management of women at high risk of IBC (e.g., by leading to the development of novel therapeutic agents targeting the molecular changes associated with invasive disease development, and by enabling chemoprevention to be targeted to specific subgroups of women).

R01CA218429

Sponsor: NIH/NCI

Subcontract to Albert Einstein College of Medicine

KPHI Co-Investigator: Stacey Honda, MD, PhD

CENTER FOR RESEARCH TO OPTIMIZE PRECISION LUNG CANCER SCREENING IN DIVERSE POPULATIONS

This project focuses on evaluating the benefits, harms, and costs of lung cancer screening and prevention in community health systems, with a particular focus on improving lung cancer screening and addressing health disparities in lung cancer-related deaths. The focus on addressing health disparities is particularly important for lung cancer, because lung cancer deaths are highest amongst medically underserved populations. The results of this work will ultimately be used to develop new interventions to decrease lung cancer deaths.

UM1CA221939

Sponsor: NIH/NCI

Subcontract to Kaiser Permanente Colorado

KPHI Principal Investigator: Stacey Honda, MD, PhD

KPHI Co-Investigator: Caryn Oshiro, PhD

UNEARTHING INTERACTING NONTUBERCULOUS MYCOBACTERIAL, ENVIRONMENTAL, AND HOST DETERMINANTS OF LUNG DISEASE IN THE HAWAII ISLANDS

This project involves collection of environmental samples and biospecimens for cases and control participants to determine factors that contribute to the development of nontuberculous mycobacterial infections.

1743587

Sponsor: NSF

Subcontract to National Jewish Health

KPHI Co-Investigator: Stacey Honda, MD, PhD

KPHI Co-Investigator: Vanessa Simiola, PsyD

A NEW PROSPECTIVE U.S. COHORT SET WITHIN THE HEALTH CARE SYSTEM INSTITUTIONS TO STUDY CANCER

This is a 10- year prospective, longitudinal biobank study to identify predictors of cancer development in healthy adults.

HHSN2612018000211

Sponsor: NIH/NCI

Subcontract to KP Colorado; Institute for Health Research

KPHI Co-Investigator: Stacey Honda, MD, PhD

KPHI Co-Investigator: Vanessa Simiola, PsyD

KAISER PERMANENTE RESEARCH BANK

This project aims to collect medical, lifestyle, demographic, environmental and genetic information on Kaiser Permanente members, to develop a greater understanding of these factors and their relationship to different diseases, in order to improve health of members and society at large. To join, visit us at: kp.org/researchbank

Sponsor: Kaiser Community Benefit

KPHI Co-Investigator: Stacey Honda, MD, PhD